G01N 2333/5431
Il-11
G01N2333/5431 (Il-11) appears on 1 US grants and 15 published applications in this corpus.
Search patents in G01N- Granted patents
- 1
- Published applications
- 15
- Assignees
- 13
- Inventors
- 65
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 4 |
| 2025 | 0 | 2 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Anti il-11 antibody1 Oct 2026US 2026/0297176 A1
- Anti-interleukin-11 antibodies and methods of use thereof10 Sep 2026US 2026/0265365 A1Boehringer Ingelheim International GmbH
- Methods of detecting and treating cerebral aneurysms19 Feb 2026US 2026/0049998 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods of detecting and treating cerebral aneurysms13 Nov 2025US 2025/0347700 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Biomarkers for the treatment of interstitial lung disease6 Mar 2025US 2025/0076312 A1Lung Therapeutics, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.